Application of novel chromium dioxide magnetic particles to immunoassay development.
We have used chromium dioxide magnetic particles as the solid support in developing a series of immunological tests. The high surface area (greater than 40 m2/g) available on the magnetic particles and their easy dispersion throughout a solution allow for rapid and complete capture of the target antigen. The magnetic responsiveness of the particles allows for rapid, high-efficiency washing to reduce nonspecific binding, which often limits the sensitivity of serological assays. These features form the basis of extremely rapid and flexible assays for several hormones and markers of cancer and infectious disease. Most of the assays involve monoclonal antibodies. Here we describe specific performance characteristics for thyroxin, follitropin, creatine kinase isoenzyme MB, and antibody to human immunodeficiency virus (HIV). All of the assays are performed in less than 90 min, many in 30 to 45 min. The technology is highly flexible and is suitable for a variety of formats, from manual to fully automated.
D000469:Alkaline Phosphatase; D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral / Q000032:analysis; D002857:Chromium; D017608:Chromium Compounds; D003402:Creatine Kinase / Q000032:analysis; D005640:Follicle Stimulating Hormone / Q000032:analysis; D006678:HIV / Q000276:immunology; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D007202:Indicators and Reagents; D007527:Isoenzymes; D008280:Magnetics; D013974:Thyroxine / Q000032:analysis
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D017608:Chromium Compounds; D007202:Indicators and Reagents; D007527:Isoenzymes; D002857:Chromium; C053245:chromium dioxide; D005640:Follicle Stimulating Hormone; D003402:Creatine Kinase; D000469:Alkaline Phosphatase; D013974:Thyroxine